L-FABP関連文献
このコーナーでは、L-FABP関連の論文を、慢性腎臓病(CKD)、急性腎障害(AKI)、Toxicology、Pharmacologyに分類し、紹介いたします。
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号(文献リストの赤色の数字)を入力の上、ご連絡ください。
文献カテゴリー
慢性腎臓病(CKD) 【新着】
-
226
Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study.
J Clin Med. 2024
doi: 10.3390/jcm13030736. PubMed -
224
Comparison of Urinary Liver Fatty Acid Binding Protein Level and Pathologic Biopsy Findings 1 Year After Kidney Transplantation.
Transplant Proc. 2024
doi: 10.1016/j.transproceed.2023.12.016. PubMed -
218
Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease.
J Pers Med. 2023
doi: 10.3390/jpm13101481. PubMed -
214
Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes.
Biomedicines. 2023
doi: 10.3390/biomedicines11113020. PubMed -
211
Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations.
Sci Rep. 2023
doi: 10.1038/s41598-023-38507-w PubMed
急性腎障害(AKI) 【新着】
-
227
Urinary liver-type fatty acid-binding protein levels may be associated with the occurrence of acute kidney injury induced by trauma.
Front Med (Lausanne). 2024
doi: 10.3389/fmed.2024.1346183. PubMed -
225
Urine oxygenation predicts COVID 19 risk.
Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed -
223
Unravelling the role of urinary liver-type fatty acid binding protein in histone-induced AKI.
Nephrology (Carlton). 2024
doi: 10.1111/nep.14271. PubMed -
222
How to Construct an Optimal Risk Model for Contrast-induced Nephropathy.
Intern Med. 2024
doi: 10.2169/internalmedicine.3209-23. PubMed -
221
The Experience of Using Urinary Liver-Type Fatty Acid-Binding Protein for Follow-Up of Toluene Poisoning: A Case Report.
Cureus. 2023
doi: 10.7759/cureus.50438. PubMed
薬剤性腎障害(Toxicology) 【新着】
-
201
Urinary liver-type fatty acid-binding protein in two dogs with acquired Fanconi syndrome: A case report. Open Vet J.2022
doi: 10.5455/OVJ.2022.v12.i6.12 PubMed -
188
Urinary L-type fatty acid-binding protein is a predictor of cisplatin-induced acute kidney injury. BMC Nephrol.2022
doi: 10.1186/s12882-022-02760-4. PubMed -
184
Clinical Utility of a Biomarker to Detect Contrast-Induced AcuteKidney Injury during Percutaneous Cardiovascular Procedures.
Cardiorenal Med.2022
doi: 10.1159/000520820. PubMed -
167
Changing trends in lipid profile and biomarkers of renalfunction and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofoviralafenamide: a prospective observational study.
AIDS Res Ther.2021
doi:10.1186/s12981-021-00354-y. PubMed -
153
Early changes in tubular dysfunction markers and phosphorusmetabolism regulators as a result of switching from entecavir to tenofovir alafenamide fumarate nucleosideanalog therapy for chronic hepatitis B patients.
Hepatol Res.2020
doi:10.1111/hepr.13451. PubMed
薬理学(Pharmacology) 【新着】
-
217
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed -
206
Markers of Kidney Tubular Function Deteriorate While Those of Kidney Tubule Health Improve in Primary Aldosteronism After Targeted Treatments.
J Am Heart Assoc.2023
doi: 10.1161/JAHA.122.028146. PubMed -
205
Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
Int Urol Nephrol.2023
doi: 10.1007/s11255-023-03532-1. PubMed -
182
Tubular Injury Causing Protracted GlycosuriaFollowing Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in theDevelopment of Protracted Hypoglycemia and Ketoacidosis.
Tohoku J ExpMed.2021
doi: 10.1620/tjem.255.291. PubMed
運動(Exercise) 【新着】
-
197
The moderate-intensity continuous exercise maintains renal blood flow and does not impair the renal function .
Physiol Rep. 2022
doi: 10.14814/phy2.15420. PubMed -
194
Xanthine Oxidoreductase Activity in MarathonRunners: Potential Implications for Marathon-Induced Acute Kidney Injury.
JAppl Physiol. 2022
doi: 10.1152/japplphysiol.00669.2021. PubMed -
181
Wearing a face mask during controlled-intensity exercise is nota risk factor for exertional heatstroke: A pilot study.
Acute MedSurg.2021
doi: 10.1002/ams2.712. PubMed -
178
Exercise Ameliorates Diabetic Kidney Disease in Type 2 DiabeticFatty Rats.
Antioxidants (Basel).2021
doi: 10.3390/antiox10111754. PubMed -
148
Effects of exercise on residual renal function in patientsundergoing peritoneal dialysis: a post-hoc analysis of a randomized controlled trial.
Ther Apher Dial.2020
PubMed
新型コロナウイルス感染症(COVID-19) 【新着】
-
225
Urine oxygenation predicts COVID 19 risk.
Clin Exp Nephrol. 2024
doi: 10.1007/s10157-023-02456-5. PubMed -
217
Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Nephrology (Carlton). 2023
doi: 10.1111/nep.14254. PubMed - J49 当院での新型コロナウイルス感染症(COVID-19)入院患者から検討した重症化予測因子 内科2023
-
209
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Nephrology (Carlton).2023
DOI: 10.1111/nep.14162 PubMed -
208
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases.
Care Explor. 2023
doi: 10.1097/CCE.0000000000000873. PubMed
日本語総説 【新着】
- J49 当院での新型コロナウイルス感染症(COVID-19)入院患者から検討した重症化予測因子 内科2023
-
J48
COVID-19と高血圧症・腎疾患
The Lipid33(1) 2022 - J47 【CKD 患者における抗がん薬治療】がん薬物療法前のAKIリスク評価とAKIバイオマーカー 腎と透析93(3) 2022
-
J46
慢性腎臓病の重症化予防に向けた運動の役割
体力科学誌2019 -
J45
習慣的な運動による老化関連疾患の予防
医学のあゆみ2018
ガイドラインなど
文献・資料をご希望の際は、資料請求ページの備考欄に見出し番号(下記リストの最初の数字)を入力の上、ご連絡ください。